Gregoire Ramade - Nov 7, 2022 Form 4 Insider Report for VAPOTHERM INC (VAPO)

Role: SVP & Chief Commercial Officer
Signature: /s/Adrain Bryant, as Attorney In Fact
Stock symbol: VAPO
Transactions as of: Nov 7, 2022
Transactions value $: $0
Form type: 4
Date filed: 11/9/2022, 03:34 PM
Previous filing: May 12, 2022
Next filing: Nov 17, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VAPO	Common Stock	Award	$0	+40K	+120.79%	$0.00	73.1K	Nov 7, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This award was granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan (as amended from time to time, the "2018 Equity Plan") in the form of restricted stock units. The restricted stock units vest with respect to approximately one-third of the underlying shares on each of the one-year, two-year and three-year anniversaries of the grant date, subject to the Reporting Person's continued service as an employee or other service provider to the Issuer through the vesting dates.
F2	Includes 59,900 shares that will be issued over time upon vesting and settlement of restricted stock units granted under the 2018 Equity Plan and the Vapotherm, Inc. Amended and Restated 2019 French Qualifying Sub Plan.

Content

This award was granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan (as amended from time to time, the "2018 Equity Plan") in the form of restricted stock units. The restricted stock units vest with respect to approximately one-third of the underlying shares on each of the one-year, two-year and three-year anniversaries of the grant date, subject to the Reporting Person's continued service as an employee or other service provider to the Issuer through the vesting dates.

Includes 59,900 shares that will be issued over time upon vesting and settlement of restricted stock units granted under the 2018 Equity Plan and the Vapotherm, Inc. Amended and Restated 2019 French Qualifying Sub Plan.